These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12639877)

  • 1. Obstacles to the initiation of beta blockers for heart failure in a specialised clinic within a district general hospital.
    Mahmoudi M; McDonagh S; Poole-Wilson P; Dubrey SW
    Heart; 2003 Apr; 89(4):442-4. PubMed ID: 12639877
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-blockers in heart failure.
    Yudkin J
    Diabet Med; 1999 Sep; 16(9):785-7. PubMed ID: 10510958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Practical advice on the treatment of cardiac insufficiency with beta-blockers. Announcement by the Italian Association of Hospital-based Cardiologists].
    Tavazzi L
    Rev Port Cardiol; 1999 May; 18(5):556-7. PubMed ID: 10475681
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.
    Maggioni AP; Sinagra G; Opasich C; Geraci E; Gorini M; Gronda E; Lucci D; Tognoni G; Balli E; Tavazzi L;
    Heart; 2003 Mar; 89(3):299-305. PubMed ID: 12591836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost minimisation analysis of cardiac failure treatment in the UK using CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
    Malek M; Cunningham-Davis J; Malek L; Paschen B; Tavakoli M; Zabihollah M; Davey P
    Int J Clin Pract; 1999; 53(1):19-23. PubMed ID: 10344061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of the cardiac insufficiency bisoprolol study II (CIBIS II). The CIBIS II Scientific Committee.
    Fundam Clin Pharmacol; 1997; 11(2):138-42. PubMed ID: 9107560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-minimization of heart failure therapy with bisoprolol in the French setting: an analysis from CIBIS trial data. Cardiac Insufficiency Bisoprolol Study.
    Levy P; Lechat P; Leizorovicz A; Levy E
    Cardiovasc Drugs Ther; 1998 Jul; 12(3):301-5. PubMed ID: 9784910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK; Loshchits NV
    Ter Arkh; 2004; 76(3):62-8. PubMed ID: 15108463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent clinical data regarding the use of beta blockers in heart failure: focus on CIBIS II.
    Dargie H
    Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV2-4. PubMed ID: 10574902
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of bisoprolol treatment for chronic heart failure initiated and followed up by primary care physicians.
    Schuchert A;
    Eur J Heart Fail; 2005 Jun; 7(4):604-11. PubMed ID: 15921801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bisoprolol on perioperative complications in chronic heart failure after surgery (Cardiac Insufficiency Bisoprolol Study II (CIBIS II)).
    Böhm M; Maack C; Wehrlen-Grandjean M; Erdmann E
    Z Kardiol; 2003 Aug; 92(8):668-76. PubMed ID: 12955414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.
    Lin TY; Chen CY; Huang YB
    Int J Cardiol; 2017 Mar; 230():378-383. PubMed ID: 28041715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial.
    Castagno D; Jhund PS; McMurray JJ; Lewsey JD; Erdmann E; Zannad F; Remme WJ; Lopez-Sendon JL; Lechat P; Follath F; Höglund C; Mareev V; Sadowski Z; Seabra-Gomes RJ; Dargie HJ
    Eur J Heart Fail; 2010 Jun; 12(6):607-16. PubMed ID: 20354032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockers for the treatment of congestive heart failure.
    Johnson S; Newton W
    J Fam Pract; 1999 Apr; 48(4):247-8. PubMed ID: 10229240
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blocker treatment in heart failure. Role of heart rate reduction.
    Lechat P
    Basic Res Cardiol; 1998; 93 Suppl 1():148-55. PubMed ID: 9833143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced costs with bisoprolol treatment for heart failure: an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II).
    Eur Heart J; 2001 Jun; 22(12):1021-31. PubMed ID: 11428837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful heart failure therapy in mitochondrial disorder with noncompaction cardiomyopathy.
    Finsterer J; Stöllberger C; Gelpi E
    Int J Cardiovasc Imaging; 2006; 22(3-4):393-8. PubMed ID: 16502323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers for mild to moderate heart failure.
    Krumholz HM
    Lancet; 1999 Jan; 353(9146):2-3. PubMed ID: 10023937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.